+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Vaccine Contract Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

  • ID: 5483495
  • Report
  • November 2021
  • Region: Global
  • 142 Pages
  • IMARC Group

FEATURED COMPANIES

  • Ajinomoto Co. Inc.
  • Catalent Inc
  • ICON plc
  • IDT Biologika GmbH
  • Lonza Group AG
  • Merck KGaA
The global vaccine contract manufacturing market exhibited strong growth during 2015-2020. Looking forward, the publisher expects the market to grow at a CAGR of around 9% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Vaccine contract manufacturing refers to the outsourcing of large-scale production of vaccines to contract manufacturing organizations (CMOs). These organizations offer numerous services, including pre-formulation work, formulation development, method development, stability studies, pre-clinical activities, registration batches and commercial manufacturing. Apart from this, they provide expertise and innovative technologies to expand the production chain of pharmaceutical companies. At present, the demand for outsourcing vaccine manufacturing activities is escalating worldwide on account of reduced development costs and complex production protocols.

Vaccination plays a pivotal role in improving human as well as veterinary health. It reduces the need for antibiotics and prevents diseases. The increasing awareness about vaccination and numerous associated benefits, such as protection from severe illnesses and infectious diseases, is catalyzing the demand for immunization programs and inoculations. This, in confluence with understanding the complexity of capital requirement for production, has led the leading pharmaceutical companies to outsource vaccine manufacturing. Apart from this, the lack of equipment and skilled labor for vaccine production in low-resource countries is also contributing to the global vaccine contract manufacturing market growth. Moreover, technological advancements, including the introduction of expression systems like the EB66 and GPEx and cell culture media platforms, are supporting the market growth. Furthermore, the alarmingly growing cases of coronavirus disease (COVID-19) in numerous countries have propelled the vaccine developers to sign outsourcing agreements with CMOs. This is creating a favorable outlook for the growth of the market.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global vaccine contract manufacturing market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, vaccine type, workflow and application.

Breakup by Vaccine Type:

  • Attenuated
  • Inactivated
  • Subunit-based
  • Toxoid-based
  • DNA-based

Breakup by Workflow:

  • Downstream
  • Fill and Finish Operations
  • Analytical and QC studies
  • Packaging
  • Upstream
  • Mammalian Expression Systems
  • Bacterial Expression Systems
  • Yeast Expression Systems
  • Baculovirus/Insect Expression Systems
  • Others

Breakup by Application:

  • Human Use
  • Veterinary

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Ajinomoto Co. Inc., Albany Molecular Research Inc, Catalent Inc, Cobra Biologics Limited (Charles River Laboratories International Inc.), Cytovance Biologics Inc. (Hepalink USA Inc.), Fujifilm Holdings Corporation, ICON plc, IDT Biologika GmbH, Lonza Group AG, Merck KGaA, Pharmaceutical Product Development LLC and PRA Health Sciences Inc.

Key Questions Answered in This Report:

  • How has the global vaccine contract manufacturing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global vaccine contract manufacturing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the vaccine type?
  • What is the breakup of the market based on the workflow?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global vaccine contract manufacturing market and who are the key players?
  • What is the degree of competition in the industry?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Ajinomoto Co. Inc.
  • Catalent Inc
  • ICON plc
  • IDT Biologika GmbH
  • Lonza Group AG
  • Merck KGaA

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Vaccine Contract Manufacturing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Vaccine Type
6.1 Attenuated
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Inactivated
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Subunit-based
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Toxoid-based
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 DNA-based
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Workflow
7.1 Downstream
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Fill and Finish Operations
7.1.2.2 Analytical and QC studies
7.1.2.3 Packaging
7.1.3 Market Forecast
7.2 Upstream
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 Mammalian Expression Systems
7.2.2.2 Bacterial Expression Systems
7.2.2.3 Yeast Expression Systems
7.2.2.4 Baculovirus/Insect Expression Systems
7.2.2.5 Others
7.2.3 Market Forecast
8 Market Breakup by Application
8.1 Human Use
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Veterinary
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Ajinomoto Co. Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Albany Molecular Research Inc
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 SWOT Analysis
14.3.3 Catalent Inc
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Cobra Biologics Limited (Charles River Laboratories International Inc.)
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Cytovance Biologics Inc. (Hepalink USA Inc.)
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Fujifilm Holdings Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 ICON plc
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 IDT Biologika GmbH
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Lonza Group AG
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Merck KGaA
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Pharmaceutical Product Development LLC
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 PRA Health Sciences Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
List of Figures
Figure 1: Global: Vaccine Contract Manufacturing Market: Major Drivers and Challenges
Figure 2: Global: Vaccine Contract Manufacturing Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Vaccine Contract Manufacturing Market: Breakup by Vaccine Type (in %), 2020
Figure 5: Global: Vaccine Contract Manufacturing Market: Breakup by Workflow (in %), 2020
Figure 6: Global: Vaccine Contract Manufacturing Market: Breakup by Application (in %), 2020
Figure 7: Global: Vaccine Contract Manufacturing Market: Breakup by Region (in %), 2020
Figure 8: Global: Vaccine Contract Manufacturing (Attenuated) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Vaccine Contract Manufacturing (Attenuated) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Vaccine Contract Manufacturing (Inactivated) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Vaccine Contract Manufacturing (Inactivated) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Vaccine Contract Manufacturing (Subunit-based) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Vaccine Contract Manufacturing (Subunit-based) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Vaccine Contract Manufacturing (Toxoid-based) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Vaccine Contract Manufacturing (Toxoid-based) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Vaccine Contract Manufacturing (DNA-based) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Vaccine Contract Manufacturing (DNA-based) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Vaccine Contract Manufacturing (Downstream) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Vaccine Contract Manufacturing (Downstream) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Vaccine Contract Manufacturing (Upstream) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Vaccine Contract Manufacturing (Upstream) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Vaccine Contract Manufacturing (Human Use) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Vaccine Contract Manufacturing (Human Use) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Vaccine Contract Manufacturing (Veterinary) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Vaccine Contract Manufacturing (Veterinary) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: North America: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: North America: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: United States: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: United States: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Canada: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Canada: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Asia-Pacific: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Asia-Pacific: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: China: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: China: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Japan: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Japan: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: India: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: India: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: South Korea: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: South Korea: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Australia: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Australia: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Indonesia: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Indonesia: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Others: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: Others: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Europe: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Europe: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Germany: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Germany: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: France: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: France: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: United Kingdom: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: United Kingdom: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Italy: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Italy: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Spain: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Spain: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Russia: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Russia: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Others: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Others: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Latin America: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Latin America: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Brazil: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Brazil: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Mexico: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Mexico: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Others: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Others: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Middle East and Africa: Vaccine Contract Manufacturing Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Middle East and Africa: Vaccine Contract Manufacturing Market: Breakup by Country (in %), 2020
Figure 74: Middle East and Africa: Vaccine Contract Manufacturing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Global: Vaccine Contract Manufacturing Industry: SWOT Analysis
Figure 76: Global: Vaccine Contract Manufacturing Industry: Value Chain Analysis
Figure 77: Global: Vaccine Contract Manufacturing Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Vaccine Contract Manufacturing Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Vaccine Contract Manufacturing Market Forecast: Breakup by Vaccine Type (in Million US$), 2021-2026
Table 3: Global: Vaccine Contract Manufacturing Market Forecast: Breakup by Workflow (in Million US$), 2021-2026
Table 4: Global: Vaccine Contract Manufacturing Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 5: Global: Vaccine Contract Manufacturing Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Vaccine Contract Manufacturing Market: Competitive Structure
Table 7: Global: Vaccine Contract Manufacturing Market: Key Players
Note: Product cover images may vary from those shown
  • Ajinomoto Co. Inc.
  • Albany Molecular Research Inc
  • Catalent Inc
  • Cobra Biologics Limited (Charles River Laboratories International Inc.)
  • Cytovance Biologics Inc. (Hepalink USA Inc.)
  • Fujifilm Holdings Corporation
  • ICON plc
  • IDT Biologika GmbH
  • Lonza Group AG
  • Merck KGaA
  • Pharmaceutical Product Development LLC
  • PRA Health Sciences Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...